Quels risques sont associés à une grossesse multiple ?
Les grossesses multiples augmentent le risque de complications pour la mère et les bébés.
Grossesse multipleGonadotrophine chorionique
#4
La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?
Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété.
Santé mentaleGonadotrophine chorionique
#5
Quels sont les effets à long terme de la gonadotrophine chorionique ?
Les effets à long terme sont généralement rares, mais un suivi est recommandé.
Effets à long termeGonadotrophine chorionique
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?
L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque.
Hyperstimulation ovarienneFacteurs de risque
#2
Comment l'âge influence-t-il la fertilité ?
L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications.
ÂgeFertilité
#3
Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?
Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement.
Antécédents médicauxGonadotrophine chorionique
#4
Quels comportements de santé peuvent affecter la fertilité ?
Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale.
Comportements de santéFertilité
#5
Y a-t-il des facteurs environnementaux qui influencent la fertilité ?
Oui, l'exposition à des toxines environnementales peut affecter la fertilité.
Facteurs environnementauxFertilité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gonadotrophine chorionique : Questions médicales les plus fréquentes",
"headline": "Gonadotrophine chorionique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gonadotrophine chorionique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011257",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.780"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gonadotrophine chorionique",
"alternateName": "Chorionic Gonadotropin",
"code": {
"@type": "MedicalCode",
"code": "D006063",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hirokazu Usui",
"url": "https://questionsmedicales.fr/author/Hirokazu%20Usui",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Asuka Sato",
"url": "https://questionsmedicales.fr/author/Asuka%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Eri Katayama",
"url": "https://questionsmedicales.fr/author/Eri%20Katayama",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Natsuko Nakamura",
"url": "https://questionsmedicales.fr/author/Natsuko%20Nakamura",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan."
}
},
{
"@type": "Person",
"name": "Kaori Koga",
"url": "https://questionsmedicales.fr/author/Kaori%20Koga",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Persistently elevated serum concentrations of human chorionic gonadotropin (hCG).",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37279342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/cclm-2023-0486"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intrauterine infusion of human chorionic gonadotropin improves the endometrial FoxP3",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35944443",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jri.2022.103678"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy.",
"datePublished": "2023-07-13",
"url": "https://questionsmedicales.fr/article/37459690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envint.2023.108091"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of a New Model for Human Chorionic Gonadotropin Rise in Pregnancies of Unknown Viability.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290108",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005235"
}
},
{
"@type": "ScholarlyArticle",
"name": "Paraneoplastic production of human chorionic gonadotropin by paratesticular dedifferentiated liposarcoma with rhabdomyosarcomatous differentiation.",
"datePublished": "2024-08-31",
"url": "https://questionsmedicales.fr/article/39216884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-254128"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011257"
},
{
"@type": "ListItem",
"position": 5,
"name": "Gonadotrophine chorionique",
"item": "https://questionsmedicales.fr/mesh/D006063"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gonadotrophine chorionique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gonadotrophine chorionique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gonadotrophine chorionique",
"description": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?\nQuels niveaux de gonadotrophine indiquent une grossesse normale ?\nPeut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?\nQuels tests sont utilisés pour mesurer la gonadotrophine chorionique ?\nQuand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gonadotrophine chorionique",
"description": "Quels symptômes indiquent une grossesse précoce ?\nLa gonadotrophine chorionique cause-t-elle des effets secondaires ?\nQuels signes peuvent indiquer une grossesse extra-utérine ?\nComment la gonadotrophine chorionique affecte-t-elle l'humeur ?\nQuels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gonadotrophine chorionique",
"description": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?\nComment réduire le risque de grossesse extra-utérine ?\nY a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?\nComment le mode de vie influence-t-il la fertilité ?\nLes femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gonadotrophine chorionique",
"description": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?\nQuels sont les traitements pour les niveaux anormaux de gonadotrophine ?\nLa gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?\nQuels médicaments contiennent de la gonadotrophine chorionique ?\nComment la gonadotrophine chorionique est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gonadotrophine chorionique",
"description": "Quelles sont les complications possibles de la gonadotrophine chorionique ?\nComment l'hyperstimulation ovarienne se manifeste-t-elle ?\nQuels risques sont associés à une grossesse multiple ?\nLa gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?\nQuels sont les effets à long terme de la gonadotrophine chorionique ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gonadotrophine chorionique",
"description": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?\nComment l'âge influence-t-il la fertilité ?\nLes antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?\nQuels comportements de santé peuvent affecter la fertilité ?\nY a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D006063#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin ou urinaire détecte la présence de la gonadotrophine chorionique."
}
},
{
"@type": "Question",
"name": "Quels niveaux de gonadotrophine indiquent une grossesse normale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux de 5 à 426 mUI/ml sont typiques au début de la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent indiquer des tumeurs germinales ou trophoblastiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer la gonadotrophine chorionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests immunologiques, comme les tests ELISA, sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand doit-on mesurer la gonadotrophine chorionique après la conception ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle doit être mesurée environ 1 à 2 semaines après la conception."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une grossesse précoce ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des seins sensibles et des retards de règles."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique cause-t-elle des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des nausées et des vomissements chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une grossesse extra-utérine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs abdominales sévères et saignements peuvent signaler une grossesse extra-utérine."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique affecte-t-elle l'humeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent entraîner des changements d'humeur chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une hyperstimulation ovarienne ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ballonnements, douleurs abdominales et prise de poids rapide peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des tests précoces peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de grossesse extra-utérine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical et une gestion des facteurs de risque peuvent réduire ce risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance attentive lors des traitements de fertilité peut prévenir l'hyperstimulation."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la fertilité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, y compris une alimentation équilibrée, peut améliorer la fertilité."
}
},
{
"@type": "Question",
"name": "Les femmes doivent-elles se faire dépister avant un traitement de fertilité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage complet est recommandé pour identifier les problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est administrée pour induire l'ovulation et soutenir la grossesse."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour les niveaux anormaux de gonadotrophine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une chirurgie."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être utilisée dans le traitement de certains types de tumeurs germinales."
}
},
{
"@type": "Question",
"name": "Quels médicaments contiennent de la gonadotrophine chorionique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'HCG sont utilisés pour la fertilité et le traitement hormonal."
}
},
{
"@type": "Question",
"name": "Comment la gonadotrophine chorionique est-elle administrée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par injection intramusculaire ou sous-cutanée."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la gonadotrophine chorionique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hyperstimulation ovarienne et les grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment l'hyperstimulation ovarienne se manifeste-t-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs abdominales, des nausées et un gonflement abdominal."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une grossesse multiple ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples augmentent le risque de complications pour la mère et les bébés."
}
},
{
"@type": "Question",
"name": "La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de la gonadotrophine chorionique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme sont généralement rares, mais un suivi est recommandé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il la fertilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quels comportements de santé peuvent affecter la fertilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux qui influencent la fertilité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fertilité."
}
}
]
}
]
}
Laboratory of Physiopathology and PharmacoToxicology of the Human Placenta, UMR-S 1139 Inserm - University Paris Descartes, Sorbonne Paris Cité, Paris, France.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea.
Animal Biotechnology, Graduate School of Future Convergence Technology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
School of Animal Life Biotechnology, Institute of Genetic Engineering, Hankyong National University, Ansung, 17579, Korea. ksmin@hknu.ac.kr.
Department of Surgery, Dentistry, Paediatrics and Gynaecology, Paediatric Fertility Lab, Woman and Child Hospital, Division of Pediatric Surgery, University of Verona, 37134 Verona, Italy.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Obstetrics and Gynaecology, Reproductive Endocrinology and Infertility Unit, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
We describe a woman with constantly elevated hCG levels in serum. Since assay interference, pregnancy or cancer did not explain the elevated levels, we measured the concentrations of hCG, its β subuni...
We used 3 assays for total hCG (these assays also recognize hCGβ and to various degrees hCGβcf), 3 for intact hCG heterodimer, 3 for free hCGβ and one for hCGβcf....
With an hCG assay detecting total hCG the serum concentrations were in the range of 150-260 IU/L for the whole study period of almost 5 years, except for a peak of 1,200 IU/L, coinciding with a sponta...
The laboratory findings are in keeping with familial hCG syndrome. However, so far the condition remains to be determined in any family members. Elevated hCG levels without any explanation are problem...
Intrauterine infusion of human chorionic gonadotropin (hCG) is suggested to have the capacity to recruit regulatory T cells (Tregs) in the endometrium. However, the pregnancy outcome for infertile wom...
Human chorionic gonadotropin (hCG) is produced by the placenta and plays an essential role in the maintenance of pregnancy. Endocrine disrupting chemicals (EDCs) have the potential to interfere with f...
To investigate the association of urinary, serum and plasma concentrations of EDCs during pregnancy with serum hCG concentrations....
We utilized data form the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy (SELMA) study. We investigated the association of 26 EDCs measured in early pregnancy urine or blood ...
In 2,039 included women, higher exposure to bisphenol A was associated with lower hCG (beta [95% CI]: -0.06 [-0.11 to -0.002]) while higher triclosan exposure was associated with a higher hCG (0.02 [0...
Higher exposure to several EDCs during pregnancy was associated with a lower hCG; and despite the small effect sizes, still indicating that the exposure may negatively affect production or secretion o...
To evaluate the performance of a new human chorionic gonadotropin (hCG) threshold model to classify pregnancies as viable or nonviable using a longitudinal cohort of individuals with pregnancy of unkn...
This is a single-center, retrospective cohort study of individuals seen at the University of Missouri from January 1, 2015, until March 1, 2020, who had at least two consecutive quantitative hCG serum...
Of an initial cohort of 1,295 individuals, 688 patients met inclusion criteria. One hundred sixty-seven individuals (24.3%) had a viable intrauterine pregnancy; 463 (67.3%) had an early pregnancy loss...
The proposed new hCG threshold model optimizes a balance between identifying potentially viable intrauterine pregnancies and minimizing misdiagnosis of ectopic pregnancies and early pregnancy losses. ...
A man in his 70s presented with a left inguinoscrotal mass. Testicular tumour markers showed markedly elevated human chorionic gonadotropin (hCG). The 24.5 cm mass was resected, and histology confirme...
Measuring serum and cerebrospinal fluid human chorionic gonadotropin (hCG) is essential for the diagnosis of intracranial germ cell tumors. There are three types of hCG-related markers in clinical use...
We investigated 19 serum samples obtained from 6 patients with histologically diagnosed germinoma treated in our institute. Serum hCGβ, intact hCG, and total hCG values were measured before, during, a...
The positivity rates of serum hCGβ, intact hCG, and total hCG were 6% (1/17), 47% (7/15), and 42% (8/19), respectively, with the latter two having significantly higher positivity rates than hCGβ (p = ...
Serum intact and total hCGs have higher detection rates than hCGβ in patients with germinoma using available commercial measurement tools....
To compare the expression profile of extracellular vesicle microRNAs (EV-miRNAs) derived from follicular fluid after a trigger with recombinant human chorionic gonadotropin (r-hCG) or with a gonadotro...
A retrospective analysis of a prospective cohort. Women undergoing in vitro fertilization at a tertiary university-affiliated hospital were recruited between 2014 and 2016. EV-miRNAs were extracted fr...
Eighty-two women were included in the r-hCG trigger group and 9 in the GnRH-a group. Of 754 EV-miRNAs screened, 135 were detected in at least 50% of the samples and expressed in both groups and were f...
Trigger with GnRH-a or r-hCG leads to distinct EV-miRNAs expression profiles and to downstream biological effects in ovarian follicles. These findings may provide an insight for the increased apoptosi...
The detection of human chorionic gonadotropin (HCG) allows for the determination of pregnancy and is thus crucial during early pregnancy testing. This study introduces a novel liquid crystal (LC) bios...
Human chorionic gonadotropin (hCG) is a glycoprotein hormone expressed in a variety of tumors and is correlated with advanced stage disease and poor prognosis. This study aimed to determine hCG expres...
The histologic materials and medical records for patients diagnosed with normal endometrium, endometrial hyperplasia with/without atypia, and endometrial carcinoma between September 2017 and September...
A total of 96 patients were included: normal endometrium (27.1%) (n=26); endometrial hyperplasia without atypia (25%) (n=24); atypical endometrial hyperplasia (22.9%) (n=22); endometrioid endometrial ...
hCG is expressed to a significantly greater degree in patients with atypical endometrial hyperplasia and endometrial carcinoma and it may be potentially used as a marker for these lesions....
Human chorionic gonadotropin (HCG) is used in clinical medicine as a particularly important indicator to determine pregnancy. In this study, it was necessary to determine whether the urine spots on ca...